Oral Biopsies: Evaluation of the Post-surgical Discomfort

Sponsor
Catholic University of the Sacred Heart (Other)
Overall Status
Completed
CT.gov ID
NCT04514263
Collaborator
(none)
80
1
23
3.5

Study Details

Study Description

Brief Summary

Aim of this study is to evaluate the post-operative course in patients undergoing diagnostic or therapeutic oral mucosal biopsies.

To evaluate the wound healing, all variables connected with the surgery (including post-operative complications) were recorded. To evaluate the psychological and behavioral impact of the post-operative discomfort, two survey tools were administered: OHIP-14 and visual number scale of pain (VNS) were administered at 6h, 7 days and 21 days after biopsy.

Condition or Disease Intervention/Treatment Phase
  • Other: OHIP-14 Administration
  • Other: VNS Administration

Study Design

Study Type:
Observational
Actual Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Post-surgical Discomfort in Patients Undergoing Diagnostic Oral Biopsies
Actual Study Start Date :
Jan 8, 2018
Actual Primary Completion Date :
Mar 8, 2019
Actual Study Completion Date :
Dec 8, 2019

Arms and Interventions

Arm Intervention/Treatment
Oral Biopsy

Patients with oral lesions undergoing diagnostic or therapeutic biopsies either for benign lesions or potentially malignant disorders or malignant lesions or salivary glands diseases.

Other: OHIP-14 Administration
All patients fulfilled the OHIP-14 questionnaire three times: six hours, seven days and twenty-one days after the biopsy

Other: VNS Administration
All patients fulfilled the VNS scale three times: six hours, seven days and twenty-one days after the biopsy

Outcome Measures

Primary Outcome Measures

  1. Correlation between the clinical healing and patient perception [Six hours after an oral biopsy]

    To evaluate whether the clinical evaluation of a wound healing shows a correspondence with the patient perception of the same process.

  2. Correlation between the clinical healing and patient perception [One week after an oral biopsy]

    To evaluate whether the clinical evaluation of a wound healing shows a correspondence with the patient perception of the same process.

  3. Correlation between the clinical healing and patient perception [Three weeks after an oral biopsy]

    To evaluate whether the clinical evaluation of a wound healing shows a correspondence with the patient perception of the same process.

Secondary Outcome Measures

  1. Correlation between OHIP-14 and VNS scale [Six hours after an oral biopsy]

    Correlation between two different tools evaluating patient perception

  2. Correlation between OHIP-14 and VNS scale [One week after an oral biopsy]

    Correlation between two different tools evaluating patient perception

  3. Correlation between OHIP-14 and VNS scale [Three weeks after an oral biopsy]

    Correlation between two different tools evaluating patient perception

  4. Clinical variables which influence the healing and patient perception [Six hours after an oral biopsy]

    To evaluate which clinical variable (systemic or local) can modify the wound healing or the patient perception.

  5. Clinical variables which influence the healing and patient perception [One week after an oral biopsy]

    To evaluate which clinical variable (systemic or local) can modify the wound healing or the patient perception.

  6. Clinical variables which influence the healing and patient perception [Three weeks after an oral biopsy]

    To evaluate which clinical variable (systemic or local) can modify the wound healing or the patient perception.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • no systemic or local contraindications for surgical treatment

  • need for an oral biopsy (both excisional and incisional).

Exclusion Criteria:

Since no absolute contraindications to oral biopsies are reported, no exclusion criteria were selected for this study, but if any relative contraindication was present (i.e. bleeding disorders) biopsy was performed after the resolution of the problem

Contacts and Locations

Locations

Site City State Country Postal Code
1 Catholic University of the Sacred Heart Rome Italy 00168

Sponsors and Collaborators

  • Catholic University of the Sacred Heart

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Carlo Lajolo, Associate Professor, Catholic University of the Sacred Heart
ClinicalTrials.gov Identifier:
NCT04514263
Other Study ID Numbers:
  • OHIP-OB
First Posted:
Aug 14, 2020
Last Update Posted:
Aug 14, 2020
Last Verified:
Aug 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 14, 2020